Stay updated with breaking news from Per Protocol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biophytis / Key word(s): Miscellaneous Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO1...
Biophytis / Key word(s): Miscellaneous Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 02-Feb-2023 / 08:00 CET/CEST Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 C...
Investegate announcements from Synairgen plc, SPRINTER Trial Results Published
Following the positive post-hoc analysis of the phase 2-3 COVA clinical study strongly supporting therapeutic potential of Sarconeos (BIO101) in the treatment of pneumonia in COVID-19 patients at risk
Biophytis / Key word(s): MiscellaneousBIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LEADERS (KOL) ON THE PHASE 2-3 COVA STUDY RESULTS OF SARCONEOS (BIO101) IN THE TREATMENT OF PNEUMONIA IN COVID-19 PATIENTS AT RISK OF RESPIRAT 01-Dec-2022 / 08:07 CET/CEST BIOPHYTIS ORGANISES A WEBCAST WITH KEY OPINION LE...